MiCo BioMed Co., Ltd. (KOSDAQ:214610)
South Korea
· Delayed Price · Currency is KRW 527.00
-22.00 (-4.01%)
At close: Mar 25, 2025, 3:30 PM KST
MiCo BioMed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -30,849 | -25,774 | -38,893 | -10,575 | -5,776 | Upgrade
|
| Depreciation & Amortization | 2,085 | 2,310 | 2,847 | 2,439 | 1,776 | Upgrade
|
| Loss (Gain) From Sale of Assets | -313.83 | -2,063 | 192.28 | 0.55 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 848.89 | 739.18 | 1,078 | - | 48.08 | Upgrade
|
| Loss (Gain) From Sale of Investments | 5,956 | 577.46 | -5.05 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 3,224 | 7,769 | - | - | Upgrade
|
| Stock-Based Compensation | 290.87 | - | - | - | 0.04 | Upgrade
|
| Provision & Write-off of Bad Debts | 285.57 | 341.4 | 4,643 | 4,218 | 289.46 | Upgrade
|
| Other Operating Activities | 8,833 | 12,500 | 8,086 | 1,322 | 9,483 | Upgrade
|
| Change in Accounts Receivable | 3,425 | 376.45 | 4,825 | -3,878 | -10,699 | Upgrade
|
| Change in Inventory | -878.86 | -1,114 | -2,222 | 500.55 | -14,652 | Upgrade
|
| Change in Accounts Payable | 1,085 | 95.75 | 12.9 | -796.42 | 1,069 | Upgrade
|
| Change in Other Net Operating Assets | -1,463 | -2,572 | -2,340 | -1,831 | -217.88 | Upgrade
|
| Operating Cash Flow | -10,696 | -11,359 | -14,006 | -8,600 | -18,679 | Upgrade
|
| Capital Expenditures | -955.55 | -385.41 | -1,625 | -2,841 | -5,761 | Upgrade
|
| Sale of Property, Plant & Equipment | 38.39 | 5,110 | 223.2 | -0 | - | Upgrade
|
| Cash Acquisitions | -1,978 | -1,622 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 170.49 | -295.88 | -35.8 | -289.93 | -261.49 | Upgrade
|
| Investment in Securities | 12,952 | -3,010 | -11,450 | -8,876 | -3,239 | Upgrade
|
| Other Investing Activities | -22.9 | -24.41 | 245.34 | -7.49 | -50.34 | Upgrade
|
| Investing Cash Flow | 6,107 | -8,565 | -12,528 | -12,595 | -9,727 | Upgrade
|
| Short-Term Debt Issued | 9,000 | 261.08 | - | 4,000 | 11,000 | Upgrade
|
| Long-Term Debt Issued | 3,000 | - | 8,937 | 20,000 | - | Upgrade
|
| Total Debt Issued | 12,000 | 261.08 | 8,937 | 24,000 | 11,000 | Upgrade
|
| Short-Term Debt Repaid | - | -6,000 | - | - | -8,000 | Upgrade
|
| Long-Term Debt Repaid | -14,084 | -16,296 | -666.44 | -938.28 | -956.47 | Upgrade
|
| Total Debt Repaid | -14,084 | -22,296 | -666.44 | -938.28 | -8,956 | Upgrade
|
| Net Debt Issued (Repaid) | -2,084 | -22,035 | 8,271 | 23,062 | 2,044 | Upgrade
|
| Issuance of Common Stock | 10,978 | 45,636 | 56.28 | 671.42 | 37,746 | Upgrade
|
| Other Financing Activities | -0 | -13.55 | - | - | - | Upgrade
|
| Financing Cash Flow | 8,894 | 23,587 | 8,327 | 23,733 | 39,789 | Upgrade
|
| Foreign Exchange Rate Adjustments | 14.83 | 11.64 | 74.07 | 418.29 | -133.61 | Upgrade
|
| Net Cash Flow | 4,319 | 3,676 | -18,133 | 2,956 | 11,250 | Upgrade
|
| Free Cash Flow | -11,652 | -11,744 | -15,631 | -11,441 | -24,440 | Upgrade
|
| Free Cash Flow Margin | -251.10% | -218.81% | -97.02% | -37.76% | -53.51% | Upgrade
|
| Free Cash Flow Per Share | -267.03 | -474.80 | -711.86 | -522.03 | -1396.60 | Upgrade
|
| Cash Interest Paid | 1,130 | 360.44 | 646.96 | 46.64 | 253.17 | Upgrade
|
| Cash Income Tax Paid | 40.05 | 71.4 | 35.16 | 1.62 | -5.33 | Upgrade
|
| Levered Free Cash Flow | -5,049 | -16,397 | 1,230 | -9,991 | -25,843 | Upgrade
|
| Unlevered Free Cash Flow | -4,196 | -14,413 | 2,746 | -9,632 | -25,409 | Upgrade
|
| Change in Net Working Capital | -8,235 | 3,552 | -17,760 | 2,153 | 23,330 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.